ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹753 Cr | ₹801 Cr | ₹656 Cr | ₹657 Cr | ₹674 Cr |
What is the latest Contingent Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹753 Cr |
Mar2023 | ₹801 Cr |
Mar2022 | ₹656 Cr |
Mar2021 | ₹657 Cr |
Mar2020 | ₹674 Cr |
How is Contingent Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹753 Cr | -5.98 | |
Mar2023 | ₹801 Cr | 22.19 | |
Mar2022 | ₹656 Cr | -0.24 | |
Mar2021 | ₹657 Cr | -2.46 | |
Mar2020 | ₹674 Cr | - |
Compare Contingent Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹88,545.6 Cr | -0.9% | 0.3% | -6.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹436,379.0 Cr | 0.8% | 7.2% | 22.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,420.0 Cr | 0.7% | 11% | 53.3% | Stock Analytics | |
CIPLA | ₹122,010.0 Cr | -2% | 4.6% | 10.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,634.0 Cr | -1.6% | 2.8% | 24.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,788.5 Cr | -1.4% | 0.7% | -5.5% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -0.9% |
0.3% |
-6.4% |
SENSEX | 0.5% |
4.2% |
8% |
You may also like the below Video Courses